Literature DB >> 11477549

Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.

F Q An1, M Matsuda, H Fujii, R F Tang, H Amemiya, Y M Dai, Y Matsumoto.   

Abstract

Most hepatocellular carcinomas (HCCs) first occur as well-differentiated HCCs, from which poorly differentiated HCC cells develop because of dedifferentiation. In this study, we try to clarify the changes of dedifferentiation and cell proliferative activity and their relationship in small HCCs (less than 3.0 cm in diameter) and try to learn the mechanism of these changes by analysing the expressions and genetic changes of proliferation-related genes p53 and beta-catenin. Of 41 surgically resected small HCCs, 11 were identified to have tumor heterogeneity. DNA from the 11 small HCCs, consisting of 29 intratumoral lesions and 11 noncancerous liver tissues adjacent to HCCs, was extracted from paraffin embedded tissue sections. Exons 5-8 of p53 gene and exon 3 of beta-catenin gene were amplified by polymerase chain reaction and analyzed by direct sequence. The serial sections were also immunostained by anti-Ki-67, p53 and beta-catenin antibody. Immunohistochemistry showed that the p53 overexpression was significantly related to the proliferative activities as evaluated by Ki-67 immunostaining and to the histological differentiation. The expression of beta-catenin was found to be heterogeneously distributed not only in various histological grades of the same tumor but also in areas of the same histological grade. p53 and beta-catenin gene mutations were detected in 1 tumor respectively, both of which were second primary HCCs and also recurred later. The p53 mutation showed the same mutation pattern in heterogeneous subpopulations. beta-catenin mutation was detected only in the less differentiated lesion but not in the well-differentiated lesion of tumor. In conclusion, our findings suggest that there was histological heterogeneity in small but established HCC, which was accompanied by increased proliferative activity and p53 overexpression. The overexpression of beta-catenin may be related to the proliferative activity and dedifferentiation of HCC. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477549     DOI: 10.1002/ijc.1367

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.

Authors:  S J Moghaddam; E N Haghighi; S Samiee; N Shahid; A R Keramati; S Dadgar; M R Zali
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

2.  CT texture analysis of pancreatic cancer.

Authors:  Kumar Sandrasegaran; Yuning Lin; Michael Asare-Sawiri; Tai Taiyini; Mark Tann
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

Review 3.  Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practice.

Authors:  Kornelius Schulze; Jessica Zucman-Rossi
Journal:  Hepat Oncol       Date:  2015-07-27

4.  Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.

Authors:  Timothy M Pawlik; Ana L Gleisner; Robert A Anders; Lia Assumpcao; Warren Maley; Michael A Choti
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

Review 5.  Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges.

Authors:  Li-Chun Lu; Chih-Hung Hsu; Chiun Hsu; Ann-Lii Cheng
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

Review 6.  Liver transplantation for hepatocellular carcinoma.

Authors:  Sudeep Tanwar; Shahid A Khan; Vijay Paul Bob Grover; Catherine Gwilt; Belinda Smith; Ashley Brown
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

7.  Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6.

Authors:  Hongcheng Sun; Huamei Tang; Dacheng Xie; Zhiliang Jia; Zhenyu Ma; Daoyan Wei; Lopa Mishra; Yong Gao; Shaojiang Zheng; Keping Xie; Zhihai Peng
Journal:  Clin Cancer Res       Date:  2015-09-02       Impact factor: 12.531

8.  Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.

Authors:  De-Chen Lin; Anand Mayakonda; Huy Q Dinh; Pinbo Huang; Lehang Lin; Xiaoping Liu; Ling-Wen Ding; Jie Wang; Benjamin P Berman; Er-Wei Song; Dong Yin; H Phillip Koeffler
Journal:  Cancer Res       Date:  2017-02-20       Impact factor: 13.312

9.  Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma.

Authors:  Lijun Wang; Jianguo Wang; Xuanyu Zhang; Jie Li; Xuyong Wei; Jun Cheng; Qi Ling; Haiyang Xie; Lin Zhou; Xiao Xu; Shusen Zheng
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

10.  Selective Retention of an Inactive Allele of the DKK2 Tumor Suppressor Gene in Hepatocellular Carcinoma.

Authors:  Yung-Feng Lin; Ling-Hui Li; Chih-Hung Lin; Mei-Hua Tsou; Ming-Tai Kiffer Chuang; Keh-Ming Wu; Tsai-Lien Liao; Jian-Chiuan Li; Wei-Jie Wang; Angela Tomita; Beverly Tomita; Shiu-Feng Huang; Shih-Feng Tsai
Journal:  PLoS Genet       Date:  2016-05-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.